HYPRO_2B | R Documentation |
Kaplan-Meier digitized data from HYPRO, figure 2B (PMID 27339116). A reported sample size of 804 for a primary endpoint of RFS in prostate cancer.
HYPRO_2B
A data frame of 804 observations and 3 variables:
time | event time (in months) | |
event | OS event indicator (0 : no event, 1 : event) |
|
arm | treatment arms (conventional fractionated, hypofractionated) | |
Incrocci L, Wortel RC, Alemayehu WG, et al. Hypofractionated versus conventionally fractionated radiotherapy for patients with localised prostate cancer (HYPRO): final efficacy results from a randomised, multicentre, open-label, phase 3 trial. Lancet Oncol 2016; 17: 1061–9.
summary(HYPRO_2B)
kmplot(HYPRO_2B)
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.